Dr. Olivia M Martinez, United States
Mutations in Latent Membrane Protein 1 of Epstein Barr Virus are Associated with Increased Risk of Post-transplant Lymphoproliferative Disorder

Dr. Masaki Yamada, Japan
Early detection of Epstein Barr virus and cytomegalovirus seronegative donors are the risk factors of chronic high Epstein-Barr viral load carriage after pediatric living-donor-dominated liver transplantation program.

Dr. Joao Seda Neto, Brazil
Unresectable hepatoblastoma and pre-transplant factors associated with event-free survival

Dr. Jorge Arroyo Orvañanos, Mexico
Cytomegalovirus Infection and Disease in Pediatric Liver Transplantation: Burden of Disease Under a Preemptive Therapy Approach

Dr. Helena Genberg, Sweden
Single-dose rituximab induction may prevent EBV viremia in paediatric kidney recipients long-term: an investigation from the Nordic Paediatric Renal Transplantation Study Group (NPRTSG)

Dr. Olga Charnaya, United States
Risk of Post-Transplant Malignancy in Pediatric Kidney Transplant Recipients is not Influenced by Induction Immunosuppression